Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding.

[1]  N. Farrell,et al.  Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure. , 2004, Journal of the American Chemical Society.

[2]  N. Farrell,et al.  Competitive reactions of interstrand and intrastrand DNA-Pt adducts: A dinuclear-platinum complex preferentially forms a 1,4-interstrand cross-link rather than a 1,2 intrastrand cross-link on binding to a GG 14-mer duplex. , 2003, Chemistry.

[3]  V. Brabec,et al.  DNA Interstrand Cross-links of the Novel Antitumor Trinuclear Platinum Complex BBR3464 , 2002, The Journal of Biological Chemistry.

[4]  V. Brabec,et al.  Conformation, Recognition by High Mobility Group Domain Proteins, and Nucleotide Excision Repair of DNA Intrastrand Cross-links of Novel Antitumor Trinuclear Platinum Complex BBR3464* , 2001, The Journal of Biological Chemistry.

[5]  N. Farrell,et al.  Kinetic analysis of the stepwise formation of a long-range DNA interstrand cross-link by a dinuclear platinum antitumor complex: evidence for aquated intermediates and formation of both kinetically and thermodynamically controlled conformers. , 2001, Journal of the American Chemical Society.

[6]  M. Zucchetti,et al.  Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  N. Farrell,et al.  BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  N. Farrell,et al.  Consequences of nucleic acid conformation on the binding of a trinuclear platinum drug. , 1999, Biochemistry.

[9]  V. Brabec,et al.  Sequence-dependent conformational changes in DNA induced by polynuclear platinum complexes. , 1999, Journal of inorganic biochemistry.

[10]  S. Chaney,et al.  Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts. , 1999, Cancer research.

[11]  V. Brabec,et al.  Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking. , 1999, Biochemistry.

[12]  V. Brabec,et al.  DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. , 1999, Biochemistry.

[13]  V. Brabec,et al.  DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)]. , 1998, European journal of biochemistry.

[14]  V. Brabec,et al.  Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes. , 1995, Biochemistry.

[15]  V. Brabec,et al.  DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Lippard,et al.  Unwinding of supercoiled DNA by platinum-ethidium and related complexes , 1992 .

[17]  P. Colson,et al.  Effect of the amine non-leaving group on the structure and stability of DNA complexes with cis-[Pt(R-NH2)2(NO3)2]. , 1991, European journal of biochemistry.

[18]  John D. Roberts,et al.  Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action. , 1991, Cancer research.

[19]  A. Rahmouni,et al.  Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Van Houten,et al.  Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues. , 1990, Biochemistry.

[21]  Christopher A. Lepre,et al.  Platinum-195 NMR kinetic and mechanistic studies of cis- and trans-diamminedichloroplatinum(II) binding to DNA , 1990 .

[22]  V. Brabec,et al.  Polarographic determination of subnanogram quantities of free platinum in reaction mixture with DNA , 1990 .

[23]  V. Brabec,et al.  Biophysical studies of the modification of DNA by antitumour platinum coordination complexes. , 1990, Biophysical chemistry.

[24]  P. Sharp,et al.  DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Macquet,et al.  Differentiation of DNA-platinum complexes by fluorescence. The use of an intercalating dye as a probe. , 1977, European journal of biochemistry.

[26]  V. Brabec.  DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. , 2002, Progress in nucleic acid research and molecular biology.

[27]  N. Farrell,et al.  Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites , 2002, JBIC Journal of Biological Inorganic Chemistry.

[28]  V. Brabec,et al.  Metal Antitumor Compounds: The Mechanism of Action of Platinum Complexes , 1989 .

[29]  A. Eastman.  The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. , 1987, Pharmacology & therapeutics.

[30]  E. Paleček,et al.  Interaction of nucleic acids with electrically charged surfaces. II. Conformational changes in double-helical polynucleotides. , 1976, Biophysical chemistry.

[31]  E. Paleček,et al.  The influence of salts andpH on polarographic currents produced by denatured DNA , 1970, Biophysik.